Weekly RSV Vaccination Estimates for U.S. Adults by Age Group and Setting

Weekly cumulative estimates of RSV vaccine doses administered to U.S. adults aged 60-74 and 75+ from retail pharmacies and physician offices. Data is sourced from IQVIA and published by data.cdc.gov, with the latest update in May 2025. It tracks vaccination progress across multiple flu seasons using MMWR weeks.

Use Cases

• Analyze trends in Cumulative_Doses by Age_Group and Setting over MMWR_Week to assess vaccination campaign progress.
• Compare weekly Doses administered between retail pharmacies and physician medical offices (Setting) for different age cohorts.
• Model vaccination coverage rates by Location_and_Flu_Season_Order to identify regional disparities in RSV immunization.
• Forecast future weekly Doses using time-series features like MMWR_Week_Order and MMWR_Year.

Strengths

• Data is updated weekly, with the latest record from May 2025.
• Provides granular breakdowns by two key age groups (60-74, 75+) and two healthcare settings.
• Includes temporal features for precise time-series analysis (MMWR_Week, MMWR_Year, Week_ID).

Limitations

• The dataset contains estimated counts, not exact administrative records, which may introduce measurement error.
• Sample size (number of rows) and geographic granularity below the national level are unknown.
• Limited to adults 60+, excluding pediatric and younger adult populations.

Provenance

Source

data.cdc.gov, sourced from IQVIA vaccination data.

Collection Method

Estimated from IQVIA data on vaccinations administered in retail pharmacies and physician medical offices.

Time Range

Weekly data across multiple flu seasons, specific start date unknown.

Freshness

Updated weekly, with data current through the week of 2025-05-16.

Geography

United States.